Hyperthermia Cancer Treatment Market (By Device Type: Infrared Hyperthermia Devices, Ultrasound Hyperthermia Devices, Microwave Hyperthermia Devices, Others; By Application: Breast Cancer, Liver Cancer, Soft Tissue Sarcoma, Head & Neck Tumors, Prostate Cancer, Others; By Treatment Method; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

4. Market Overview

    4.1. Introduction

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunity

    4.3. Global Hyperthermia Cancer Treatment Market Forecast

    4.4. Global Hyperthermia Cancer Treatment Market Outlook

5. Market Outlook

    5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    5.2. Epidemiology of Cancer Globally/Country

    5.3. Reimbursement Scenario 

    5.4. Regulatory Scenario 

    5.5. Overview on Combination Cancer Treatment Strategies along with Hyperthermia

6. Global Hyperthermia Cancer Treatment Market Analysis, by Device Type

    6.1. Introduction

    6.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

    6.3. Global Hyperthermia Cancer Treatment Market Forecast, by Device Type

        6.3.1. Infrared Hyperthermia Devices

        6.3.2. Ultrasound Hyperthermia Devices

        6.3.3. Microwave Hyperthermia Devices

        6.3.4. Others

    6.4. Global Hyperthermia Cancer Treatment Market Analysis, by Device Type

7. Global Hyperthermia Cancer Treatment Market Analysis, by Treatment Method

    7.1. Introduction 

    7.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    7.3. Global Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        7.3.1. Locoregional

            7.3.1.1. External & Interstitial

            7.3.1.2. Intraluminal or Endocavitary Methods

            7.3.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            7.3.1.4. Deep Tissue & Regional Perfusion

        7.3.2. Whole-body

    7.4. Global Hyperthermia Cancer Treatment Market Analysis, by Treatment Method

8. Global Hyperthermia Cancer Treatment Market Analysis, by Application

    8.1. Introduction 

    8.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    8.3. Global Hyperthermia Cancer Treatment Market Forecast, by Application

        8.3.1. Breast Cancer

        8.3.2. Liver Cancer

        8.3.3. Soft Tissue Sarcoma

        8.3.4. Head & Neck Tumors

        8.3.5. Prostate Cancer

        8.3.6. Others

    8.4. Global Hyperthermia Cancer Treatment Market Analysis, by Application

9. Global Hyperthermia Cancer Treatment Market Analysis, by End-user

    9.1. Introduction

    9.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

    9.3. Global Hyperthermia Cancer Treatment Market Forecast, by End-user

        9.3.1. Hospitals & Specialty Clinics

        9.3.2. Ambulatory Surgical Centers

        9.3.3. Others

    9.4. Global Hyperthermia Cancer Treatment Market Analysis, by End-user

10. Global Hyperthermia Cancer Treatment Market Analysis, by Region

    10.1. Global Hyperthermia Cancer Treatment Market Scenario, by Region/Country

    10.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Region

    10.3. Global Hyperthermia Cancer Treatment Market Forecast, by Region

        10.3.1. North America

        10.3.2. Europe

        10.3.3. Asia Pacific

        10.3.4. Latin America

        10.3.5. Middle East & Africa

11. North America Hyperthermia Cancer Treatment Market Analysis

    11.1. North America Hyperthermia Cancer Treatment Market Overview

    11.2. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country

    11.3. North America Hyperthermia Cancer Treatment Market Forecast, by Country

        11.3.1. U.S.

        11.3.2. Canada

    11.4. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

    11.5. North America Hyperthermia Cancer Treatment Market Forecast, by Device Type

        11.5.1. Infrared Hyperthermia Devices

        11.5.2. Ultrasound Hyperthermia Devices

        11.5.3. Microwave Hyperthermia Devices

        11.5.4. Others

    11.6. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    11.7. North America Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        11.7.1. Locoregional

            11.7.1.1. External & Interstitial

            11.7.1.2. Intraluminal or Endocavitary Methods

            11.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            11.7.1.4. Deep Tissue & Regional Perfusion

        11.7.2. Whole-body

    11.8. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    11.9. North America Hyperthermia Cancer Treatment Market Forecast, by Application

        11.9.1. Breast Cancer

        11.9.2. Liver Cancer

        11.9.3. Soft Tissue Sarcoma

        11.9.4. Head & Neck Tumors

        11.9.5. Prostate Cancer

        11.9.6. Others

    11.10. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

    11.11. North America Hyperthermia Cancer Treatment Market Forecast, by End-user

        11.11.1. Hospitals & Specialty Clinics

        11.11.2. Ambulatory Surgical Centers

        11.11.3. Others 

12. Europe Hyperthermia Cancer Treatment Market Analysis

    12.1. Europe Hyperthermia Cancer Treatment Market Overview

    12.2. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

    12.3. Europe Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

        12.3.1. Germany

        12.3.2. France

        12.3.3. U.K.

        12.3.4. Italy

        12.3.5. Spain

        12.3.6. Rest of Europe

    12.4. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

    12.5. Europe Hyperthermia Cancer Treatment Market Forecast, by Device Type

        12.5.1. Infrared Hyperthermia Devices

        12.5.2. Ultrasound Hyperthermia Devices

        12.5.3. Microwave Hyperthermia Devices

        12.5.4. Others

    12.6. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    12.7. Europe Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        12.7.1. Locoregional

            12.7.1.1. External & Interstitial

            12.7.1.2. Intraluminal or Endocavitary Methods

            12.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            12.7.1.4. Deep Tissue & Regional Perfusion

        12.7.2. Whole-body

    12.8. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    12.9. Europe Hyperthermia Cancer Treatment Market Forecast, by Application

        12.9.1. Breast Cancer

        12.9.2. Liver Cancer

        12.9.3. Soft Tissue Sarcoma

        12.9.4. Head & Neck Tumors

        12.9.5. Prostate Cancer

        12.9.6. Others

    12.10. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

    12.11. Europe Hyperthermia Cancer Treatment Market Forecast, by End-user

        12.11.1. Hospitals & Specialty Clinics

        12.11.2. Ambulatory Surgical Centers

        12.11.3. Others 

13. Asia Pacific Hyperthermia Cancer Treatment Market Analysis

    13.1. Asia Pacific Hyperthermia Cancer Treatment Market Overview

    13.2. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

    13.3. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

        13.3.1. Japan

        13.3.2. China

        13.3.3. India

        13.3.4. Australia & New Zealand

        13.3.5. Rest of Asia Pacific

    13.4. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

    13.5. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Device Type

        13.5.1. Infrared Hyperthermia Devices

        13.5.2. Ultrasound Hyperthermia Devices

        13.5.3. Microwave Hyperthermia Devices

        13.5.4. Others

    13.6. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    13.7. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        13.7.1. Locoregional

            13.7.1.1. External & Interstitial

            13.7.1.2. Intraluminal or Endocavitary Methods

            13.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            13.7.1.4. Deep Tissue & Regional Perfusion

        13.7.2. Whole-body

    13.8. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    13.9. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Application

        13.9.1. Breast Cancer

        13.9.2. Liver Cancer

        13.9.3. Soft Tissue Sarcoma

        13.9.4. Head & Neck Tumors

        13.9.5. Prostate Cancer

        13.9.6. Others

    13.10. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

    13.11. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by End-user

        13.11.1. Hospitals & Specialty Clinics

        13.11.2. Ambulatory Surgical Centers

        13.11.3. Others 

14. Latin America Hyperthermia Cancer Treatment Market Analysis

    14.1. Latin America Hyperthermia Cancer Treatment Market Overview

    14.2. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

    14.3. Latin America Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

        14.3.1. Brazil

        14.3.2. Mexico

        14.3.3. Rest of Latin America

    14.4. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

    14.5. Latin America Hyperthermia Cancer Treatment Market Forecast, by Device Type

        14.5.1. Infrared Hyperthermia Devices

        14.5.2. Ultrasound Hyperthermia Devices

        14.5.3. Microwave Hyperthermia Devices

        14.5.4. Others

    14.6. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    14.7. Latin America Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        14.7.1. Locoregional

            14.7.1.1. External & Interstitial

            14.7.1.2. Intraluminal or Endocavitary Methods

            14.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            14.7.1.4. Deep Tissue & Regional Perfusion

        14.7.2. Whole-body

    14.8. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    14.9. Latin America Hyperthermia Cancer Treatment Market Forecast, by Application

        14.9.1. Breast Cancer

        14.9.2. Liver Cancer

        14.9.3. Soft Tissue Sarcoma

        14.9.4. Head & Neck Tumors

        14.9.5. Prostate Cancer

        14.9.6. Others

    14.10. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

    14.11. Latin America Hyperthermia Cancer Treatment Market Forecast, by End-user

        14.11.1. Hospitals & Specialty Clinics

        14.11.2. Ambulatory Surgical Centers

        14.11.3. Others

15. Middle East & Africa Hyperthermia Cancer Treatment Market Analysis

    15.1. Middle East & Africa Hyperthermia Cancer Treatment Market Overview

    15.2. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

    15.3. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region

        15.3.1. GCC Countries

        15.3.2. South Africa

        15.3.3. Rest of Middle East & Africa

    15.4. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type

    15.5. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Device Type

        15.5.1. Infrared Hyperthermia Devices

        15.5.2. Ultrasound Hyperthermia Devices

        15.5.3. Microwave Hyperthermia Devices

        15.5.4. Others

    15.6. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method

    15.7. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Treatment Method

        15.7.1. Locoregional

            15.7.1.1. External & Interstitial

            15.7.1.2. Intraluminal or Endocavitary Methods

            15.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)

            15.7.1.4. Deep Tissue & Regional Perfusion

        15.7.2. Whole-body

    15.8. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application

    15.9. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Application

        15.9.1. Breast Cancer

        15.9.2. Liver Cancer

        15.9.3. Soft Tissue Sarcoma

        15.9.4. Head & Neck Tumors

        15.9.5. Prostate Cancer

        15.9.6. Others

    15.10. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user

    15.11. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by End-user

        15.11.1. Hospitals & Specialty Clinics

        15.11.2. Ambulatory Surgical Centers

        15.11.3. Others

16. Competition Landscape

    16.1. Competition Matrix

    16.2. Company Profiles

        16.2.1. Pyrexar Medical

            16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.1.2. Product Portfolio

            16.2.1.3. SWOT Analysis

            16.2.1.4. Strategic Overview

        16.2.2. Celsius42 GmbH

            16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.2.2. Product Portfolio

            16.2.2.3. SWOT Analysis

            16.2.2.4. Strategic Overview

        16.2.3. Hydrosun GmbH

            16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.3.2. Product Portfolio

            16.2.3.3. SWOT Analysis

            16.2.3.4. Strategic Overview

        16.2.4. Oncotherm Kft

            16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.4.2. Product Portfolio

            16.2.4.3. SWOT Analysis

            16.2.4.4. Strategic Overview

        16.2.5. Andromedic S.r.l.

            16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.5.2. Product Portfolio

            16.2.5.3. SWOT Analysis

            16.2.5.4. Strategic Overview

        16.2.6. Yamamoto Vinita Co., Ltd.

            16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.6.2. Product Portfolio

            16.2.6.3. SWOT Analysis

            16.2.6.4. Strategic Overview

        16.2.7. Chongqing Haifu Medical Technology Co., Ltd

            16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.7.2. Product Portfolio

            16.2.7.3. SWOT Analysis

            16.2.7.4. Strategic Overview

        16.2.8. innoMedicus Ltd.

            16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.8.2. Product Portfolio

            16.2.8.3. SWOT Analysis

            16.2.8.4. Strategic Overview

        16.2.9. Gamida

            16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.9.2. Product Portfolio

            16.2.9.3. SWOT Analysis

            16.2.9.4. Strategic Overview

        16.2.10. RanD.

            16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.10.2. Product Portfolio

            16.2.10.3. SWOT Analysis

            16.2.10.4. Strategic Overview